---
layout: default
title: DRBD-Mamba for Robust and Efficient Brain Tumor Segmentation with Analytical Insights
---

# DRBD-Mamba for Robust and Efficient Brain Tumor Segmentation with Analytical Insights

<div class="paper-toolbar">
  <div class="toolbar-left">
    <a href="https://arxiv.org/abs/2510.14383" target="_blank" class="toolbar-btn">arXiv: 2510.14383v2</a>
    <a href="https://arxiv.org/pdf/2510.14383.pdf" target="_blank" class="toolbar-btn">PDF</a>
  </div>
  <div class="toolbar-right">
    <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.14383v2" 
            onclick="toggleFavorite(this, '2510.14383v2', 'DRBD-Mamba for Robust and Efficient Brain Tumor Segmentation with Analytical Insights')" title="Êî∂Ëóè">
      ‚òÜ Êî∂Ëóè
    </button>
    <button class="toolbar-btn share-btn" onclick="copyLink()" title="Â§çÂà∂ÈìæÊé•">
      üîó ÂàÜ‰∫´
    </button>
  </div>
</div>


**‰ΩúËÄÖ**: Danish Ali, Ajmal Mian, Naveed Akhtar, Ghulam Mubashar Hassan

**ÂàÜÁ±ª**: cs.CV

**ÂèëÂ∏ÉÊó•Êúü**: 2025-10-16 (Êõ¥Êñ∞: 2025-10-28)

---

## üí° ‰∏ÄÂè•ËØùË¶ÅÁÇπ

**ÊèêÂá∫DRBD-MambaÊ®°ÂûãÔºåÁî®‰∫éÈ≤ÅÊ£íÈ´òÊïàÁöÑËÑëËÇøÁò§ÂàÜÂâ≤ÔºåÂπ∂Êèê‰æõÂàÜÊûêÊÄßËßÅËß£**

üéØ **ÂåπÈÖçÈ¢ÜÂüü**: **ÊîØÊü±‰∫åÔºöRLÁÆóÊ≥ï‰∏éÊû∂ÊûÑ (RL & Architecture)**

**ÂÖ≥ÈîÆËØç**: `ËÑëËÇøÁò§ÂàÜÂâ≤` `MambaÊ®°Âûã` `Áä∂ÊÄÅÁ©∫Èó¥Ê®°Âûã` `ÂåªÂ≠¶ÂΩ±ÂÉèÂàÜÊûê` `Ê∑±Â∫¶Â≠¶‰π†` `Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫ø` `ÂèåÂêëÁΩëÁªú`

## üìã Ê†∏ÂøÉË¶ÅÁÇπ

1. ËÑëËÇøÁò§ÂàÜÂâ≤Èù¢‰∏¥ËÇøÁò§ÂºÇË¥®ÊÄßÊåëÊàòÔºåÁé∞ÊúâÊñπÊ≥ïËÆ°ÁÆóÂºÄÈîÄÂ§ßÔºå‰∏îÂú®‰∏çÂêåÊï∞ÊçÆÈõÜ‰∏äÁöÑÈ≤ÅÊ£íÊÄß‰∏çË∂≥„ÄÇ
2. ÊèêÂá∫ÂèåÂàÜËæ®ÁéáÂèåÂêëMambaÔºàDRBD-MambaÔºâÊ®°ÂûãÔºåÂà©Áî®Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫øÂíåÈó®ÊéßËûçÂêàÊ®°ÂùóÔºåÊèêÂçáÊïàÁéáÂíåÈ≤ÅÊ£íÊÄß„ÄÇ
3. Âú®BraTS2023Êï∞ÊçÆÈõÜ‰∏äÔºåDRBD-MambaÂú®ÂàÜÂâ≤Á≤æÂ∫¶ÂíåËÆ°ÁÆóÊïàÁéá‰∏äÂùá‰ºò‰∫éÁé∞ÊúâÊñπÊ≥ïÔºåÊïàÁéáÊèêÂçá15ÂÄç„ÄÇ

## üìù ÊëòË¶ÅÔºà‰∏≠ÊñáÔºâ

Á≤æÁ°ÆÁöÑËÑëËÇøÁò§ÂàÜÂâ≤ÂØπ‰∫é‰∏¥Â∫äËØäÊñ≠ÂíåÊ≤ªÁñóËá≥ÂÖ≥ÈáçË¶ÅÔºå‰ΩÜÁî±‰∫éËÇøÁò§ÁöÑÂºÇË¥®ÊÄßËÄå‰ªçÁÑ∂ÂÖ∑ÊúâÊåëÊàòÊÄß„ÄÇÂü∫‰∫éMambaÁöÑÁä∂ÊÄÅÁ©∫Èó¥Ê®°ÂûãÂ∑≤ÁªèÂ±ïÁ§∫Âá∫‰ª§‰∫∫ÈºìËàûÁöÑÊÄßËÉΩ„ÄÇÁÑ∂ËÄåÔºåÂ∞ΩÁÆ°ÂÆÉ‰ª¨ÊØîÂÖ∂‰ªñÁ•ûÁªèÊû∂ÊûÑÂÖ∑ÊúâÊõ¥È´òÁöÑËÆ°ÁÆóÊïàÁéáÔºå‰ΩÜÁî±‰∫éÂÆÉ‰ª¨Âú®Â§ö‰∏™Á©∫Èó¥ËΩ¥‰∏äÁöÑÈ°∫Â∫èÁâπÂæÅËÆ°ÁÆóÔºåÂõ†Ê≠§ÂØπ‰∫éÊ≠§‰ªªÂä°‰ºö‰∫ßÁîüÁõ∏ÂΩìÂ§ßÁöÑÂºÄÈîÄ„ÄÇÊ≠§Â§ñÔºåÂÆÉ‰ª¨Âú®‰∏çÂêåÁöÑBraTSÊï∞ÊçÆÂàÜÂå∫‰∏≠ÁöÑÈ≤ÅÊ£íÊÄßÂú®ÂæàÂ§ßÁ®ãÂ∫¶‰∏äÂ∞öÊú™Ë¢´Êé¢Á¥¢ÔºåËøôÂú®ÂèØÈù†ÁöÑËØÑ‰º∞‰∏≠Áïô‰∏ã‰∫Ü‰∏Ä‰∏™ÂÖ≥ÈîÆÁöÑÁ©∫ÁôΩ„ÄÇ‰∏∫‰∫ÜËß£ÂÜ≥Ëøô‰∏™ÈóÆÈ¢òÔºåÊàë‰ª¨È¶ñÂÖàÊèêÂá∫‰∫Ü‰∏ÄÁßçÂèåÂàÜËæ®ÁéáÂèåÂêëMambaÔºàDRBD-MambaÔºâÔºåËøôÊòØ‰∏ÄÁßçÈ´òÊïàÁöÑ3DÂàÜÂâ≤Ê®°ÂûãÔºåÂèØ‰ª•‰ª•ÊúÄÂ∞èÁöÑËÆ°ÁÆóÂºÄÈîÄÊçïËé∑Â§öÂ∞∫Â∫¶ËøúÁ®ã‰æùËµñÂÖ≥Á≥ª„ÄÇÊàë‰ª¨Âà©Áî®Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫øÊù•‰øùÊåÅ3DÂà∞1DÁâπÂæÅÊò†Â∞ÑÊúüÈó¥ÁöÑÁ©∫Èó¥Â±ÄÈÉ®ÊÄßÔºå‰ªéËÄåÂáèÂ∞ëÂØπËÆ°ÁÆóÊòÇË¥µÁöÑÂ§öËΩ¥ÁâπÂæÅÊâ´ÊèèÁöÑ‰æùËµñ„ÄÇ‰∏∫‰∫Ü‰∏∞ÂØåÁâπÂæÅË°®Á§∫ÔºåÊàë‰ª¨ÊèêÂá∫‰∫Ü‰∏Ä‰∏™Èó®ÊéßËûçÂêàÊ®°ÂùóÔºåËØ•Ê®°ÂùóËá™ÈÄÇÂ∫îÂú∞Êï¥ÂêàÂâçÂêëÂíåÂèçÂêë‰∏ä‰∏ãÊñáÔºå‰ª•Âèä‰∏Ä‰∏™ÈáèÂåñÂùóÔºåÂèØ‰ª•ÊèêÈ´òÈ≤ÅÊ£íÊÄß„ÄÇÊàë‰ª¨Ëøõ‰∏ÄÊ≠•Âú®BraTS2023‰∏äÊèêÂá∫‰∫Ü‰∫î‰∏™Á≥ªÁªüÊäòÂè†ÔºåÁî®‰∫éÂú®‰∏çÂêåÊù°‰ª∂‰∏ãÂØπÂàÜÂâ≤ÊäÄÊúØËøõË°å‰∏•Ê†ºËØÑ‰º∞ÔºåÂπ∂ÂØπÂ∏∏ËßÅÁöÑÂ§±Ë¥•Âú∫ÊôØËøõË°åÂàÜÊûê„ÄÇÂú®ÊúÄÊñ∞ÊñπÊ≥ï‰ΩøÁî®ÁöÑ20%ÊµãËØïÈõÜ‰∏äÔºåÊàë‰ª¨ÁöÑÊ®°ÂûãÂú®ÂÖ®ËÇøÁò§„ÄÅËÇøÁò§Ê†∏ÂøÉÂíåÂ¢ûÂº∫ËÇøÁò§ÁöÑDiceÁ≥ªÊï∞‰∏äÂàÜÂà´ÊèêÈ´ò‰∫Ü0.10%„ÄÅ1.75%Âíå0.93%„ÄÇÂú®ÊèêÂá∫ÁöÑÁ≥ªÁªüÊäòÂè†‰∏äÁöÑËØÑ‰º∞Ë°®ÊòéÔºåÊàë‰ª¨ÁöÑÊ®°Âûã‰øùÊåÅ‰∫ÜÂÖ∑ÊúâÁ´û‰∫âÂäõÁöÑÂÖ®ËÇøÁò§ÂáÜÁ°ÆÁéáÔºåÂêåÊó∂Âú®ËÇøÁò§Ê†∏ÂøÉÂíåÂ¢ûÂº∫ËÇøÁò§‰∏äÂÆûÁé∞‰∫ÜÊØîÁé∞ÊúâÊúÄÂÖàËøõÊäÄÊúØÂàÜÂà´È´òÂá∫1.16%Âíå1.68%ÁöÑÂπ≥ÂùáDiceÂ¢ûÁõä„ÄÇÊ≠§Â§ñÔºåÊàë‰ª¨ÁöÑÊ®°ÂûãÂÆûÁé∞‰∫Ü15ÂÄçÁöÑÊïàÁéáÊèêÂçáÔºåÂêåÊó∂‰øùÊåÅ‰∫ÜËæÉÈ´òÁöÑÂàÜÂâ≤ÂáÜÁ°ÆÁéáÔºåÁ™ÅÂá∫‰∫ÜÂÖ∂Áõ∏ÂØπ‰∫éÁé∞ÊúâÊñπÊ≥ïÁöÑÈ≤ÅÊ£íÊÄßÂíåËÆ°ÁÆó‰ºòÂäø„ÄÇ

## üî¨ ÊñπÊ≥ïËØ¶Ëß£

**ÈóÆÈ¢òÂÆö‰πâ**ÔºöËÑëËÇøÁò§ÂàÜÂâ≤Êó®Âú®ÂáÜÁ°ÆËØÜÂà´ÂåªÂ≠¶ÂõæÂÉè‰∏≠ÁöÑËÇøÁò§Âå∫ÂüüÔºåÂØπËØäÊñ≠ÂíåÊ≤ªÁñóËá≥ÂÖ≥ÈáçË¶Å„ÄÇÁé∞ÊúâÂü∫‰∫éMambaÁöÑÊ®°ÂûãËôΩÁÑ∂Âú®ËÆ°ÁÆóÊïàÁéá‰∏äÊúâÊâÄÊèêÂçáÔºå‰ΩÜÁî±‰∫éÂÖ∂Âú®Â§ö‰∏™Á©∫Èó¥ËΩ¥‰∏äÁöÑÈ°∫Â∫èÁâπÂæÅËÆ°ÁÆóÔºå‰ªçÁÑ∂Â≠òÂú®ËÆ°ÁÆóÂºÄÈîÄÂ§ßÁöÑÈóÆÈ¢ò„ÄÇÊ≠§Â§ñÔºåËøô‰∫õÊ®°ÂûãÂú®‰∏çÂêåÊï∞ÊçÆÈõÜ‰∏äÁöÑÈ≤ÅÊ£íÊÄßÊúâÂæÖÊèêÈ´òÔºåÁº∫‰πèÁ≥ªÁªüÊÄßÁöÑËØÑ‰º∞„ÄÇ

**Ê†∏ÂøÉÊÄùË∑Ø**ÔºöDRBD-MambaÁöÑÊ†∏ÂøÉÊÄùË∑ØÊòØÈÄöËøáÂèåÂàÜËæ®ÁéáÂ§ÑÁêÜÂíåÂèåÂêëMambaÁªìÊûÑÔºåÂú®‰øùËØÅÂàÜÂâ≤Á≤æÂ∫¶ÁöÑÂâçÊèê‰∏ãÔºåÊòæËëóÈôç‰ΩéËÆ°ÁÆóÂ§çÊùÇÂ∫¶ÔºåÂπ∂ÊèêÂçáÊ®°ÂûãÁöÑÈ≤ÅÊ£íÊÄß„ÄÇÂà©Áî®Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫ø‰øùÊåÅÁ©∫Èó¥Â±ÄÈÉ®ÊÄßÔºåÂáèÂ∞ëÂØπÂ§öËΩ¥ÁâπÂæÅÊâ´ÊèèÁöÑ‰æùËµñÔºå‰ªéËÄåÈôç‰ΩéËÆ°ÁÆóÂºÄÈîÄ„ÄÇÈÄöËøáÈó®ÊéßËûçÂêàÊ®°ÂùóËá™ÈÄÇÂ∫îÂú∞Êï¥ÂêàÂâçÂêëÂíåÂèçÂêë‰∏ä‰∏ãÊñáÔºåÂ¢ûÂº∫ÁâπÂæÅË°®Á§∫„ÄÇ

**ÊäÄÊúØÊ°ÜÊû∂**ÔºöDRBD-MambaÊ®°Âûã‰∏ªË¶ÅÂåÖÂê´‰ª•‰∏ãÂá†‰∏™ÂÖ≥ÈîÆÊ®°ÂùóÔºö
1. **ÂèåÂàÜËæ®ÁéáÂ§ÑÁêÜ**ÔºöÈááÁî®‰∏§ÁßçÂàÜËæ®ÁéáÁöÑËæìÂÖ•Ôºå‰ª•ÊçïËé∑‰∏çÂêåÂ∞∫Â∫¶ÁöÑÁâπÂæÅ‰ø°ÊÅØ„ÄÇ
2. **Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫ø**ÔºöÂ∞Ü3DÁâπÂæÅÊò†Â∞ÑÂà∞1DÂ∫èÂàóÔºå‰ª•ÂáèÂ∞ëËÆ°ÁÆóÂ§çÊùÇÂ∫¶„ÄÇ
3. **ÂèåÂêëMamba**ÔºöÂà©Áî®ÂâçÂêëÂíåÂèçÂêëÁöÑMambaÁªìÊûÑÔºåÊçïËé∑‰∏ä‰∏ãÊñá‰ø°ÊÅØ„ÄÇ
4. **Èó®ÊéßËûçÂêàÊ®°Âùó**ÔºöËá™ÈÄÇÂ∫îÂú∞ËûçÂêàÂâçÂêëÂíåÂèçÂêë‰∏ä‰∏ãÊñáÁâπÂæÅ„ÄÇ
5. **ÈáèÂåñÂùó**ÔºöÊèêÈ´òÊ®°ÂûãÁöÑÈ≤ÅÊ£íÊÄß„ÄÇ

**ÂÖ≥ÈîÆÂàõÊñ∞**ÔºöDRBD-MambaÁöÑÂÖ≥ÈîÆÂàõÊñ∞Âú®‰∫éÔºö
1. **ÂèåÂàÜËæ®ÁéáÂèåÂêëMambaÁªìÊûÑ**ÔºöÁªìÂêà‰∫ÜÂèåÂàÜËæ®ÁéáÂ§ÑÁêÜÂíåÂèåÂêëMambaÔºåÂú®‰øùËØÅÁ≤æÂ∫¶ÁöÑÂêåÊó∂ÔºåÊòæËëóÈôç‰Ωé‰∫ÜËÆ°ÁÆóÂ§çÊùÇÂ∫¶„ÄÇ
2. **Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫øÁöÑÂ∫îÁî®**ÔºöÈÄöËøáÁ©∫Èó¥Â°´ÂÖÖÊõ≤Á∫ø‰øùÊåÅÁ©∫Èó¥Â±ÄÈÉ®ÊÄßÔºåÂáèÂ∞ë‰∫ÜÂØπÂ§öËΩ¥ÁâπÂæÅÊâ´ÊèèÁöÑ‰æùËµñ„ÄÇ
3. **Èó®ÊéßËûçÂêàÊ®°Âùó**ÔºöËá™ÈÄÇÂ∫îÂú∞ËûçÂêàÂâçÂêëÂíåÂèçÂêë‰∏ä‰∏ãÊñáÁâπÂæÅÔºåÂ¢ûÂº∫‰∫ÜÁâπÂæÅË°®Á§∫„ÄÇ

**ÂÖ≥ÈîÆËÆæËÆ°**Ôºö
1. **Á©∫Èó¥Â°´ÂÖÖÊõ≤Á∫øÁöÑÈÄâÊã©**ÔºöËÆ∫ÊñáÈÄâÊã©‰∫ÜÁâπÂÆöÁöÑÁ©∫Èó¥Â°´ÂÖÖÊõ≤Á∫øÔºå‰ª•ÊúÄÂ§ßÁ®ãÂ∫¶Âú∞‰øùÊåÅÁ©∫Èó¥Â±ÄÈÉ®ÊÄß„ÄÇ
2. **Èó®ÊéßËûçÂêàÊ®°ÂùóÁöÑÁªìÊûÑ**ÔºöÈó®ÊéßËûçÂêàÊ®°ÂùóÈááÁî®ÁâπÂÆöÁöÑÈó®ÊéßÊú∫Âà∂Ôºå‰ª•Ëá™ÈÄÇÂ∫îÂú∞ËûçÂêàÂâçÂêëÂíåÂèçÂêë‰∏ä‰∏ãÊñáÁâπÂæÅ„ÄÇ
3. **ÈáèÂåñÂùóÁöÑËÆæËÆ°**ÔºöÈáèÂåñÂùóÈááÁî®ÁâπÂÆöÁöÑÈáèÂåñÁ≠ñÁï•Ôºå‰ª•ÊèêÈ´òÊ®°ÂûãÁöÑÈ≤ÅÊ£íÊÄß„ÄÇ
4. **ÊçüÂ§±ÂáΩÊï∞**Ôºö‰ΩøÁî®‰∫ÜDiceÊçüÂ§±ÂáΩÊï∞Á≠âÂ∏∏Áî®ÁöÑÂàÜÂâ≤ÊçüÂ§±ÂáΩÊï∞„ÄÇ

## üìä ÂÆûÈ™å‰∫ÆÁÇπ

DRBD-MambaÂú®BraTS2023Êï∞ÊçÆÈõÜ‰∏äÂèñÂæó‰∫ÜÊòæËëóÁöÑÊÄßËÉΩÊèêÂçá„ÄÇÂú®20%ÁöÑÊµãËØïÈõÜ‰∏äÔºåÂÖ®ËÇøÁò§„ÄÅËÇøÁò§Ê†∏ÂøÉÂíåÂ¢ûÂº∫ËÇøÁò§ÁöÑDiceÁ≥ªÊï∞ÂàÜÂà´ÊèêÈ´ò‰∫Ü0.10%„ÄÅ1.75%Âíå0.93%„ÄÇÂú®ÊèêÂá∫ÁöÑÁ≥ªÁªüÊäòÂè†‰∏äÔºåËÇøÁò§Ê†∏ÂøÉÂíåÂ¢ûÂº∫ËÇøÁò§ÁöÑÂπ≥ÂùáDiceÂ¢ûÁõäÂàÜÂà´ËææÂà∞1.16%Âíå1.68%„ÄÇÊ≠§Â§ñÔºåËØ•Ê®°ÂûãÂÆûÁé∞‰∫Ü15ÂÄçÁöÑÊïàÁéáÊèêÂçáÔºåÁ™ÅÂá∫‰∫ÜÂÖ∂ËÆ°ÁÆó‰ºòÂäø„ÄÇ

## üéØ Â∫îÁî®Âú∫ÊôØ

ËØ•Á†îÁ©∂ÊàêÊûúÂèØÂ∫îÁî®‰∫éÂåªÂ≠¶ÂΩ±ÂÉèÂàÜÊûêÈ¢ÜÂüüÔºåÁâπÂà´ÊòØËÑëËÇøÁò§ÁöÑËá™Âä®ÂàÜÂâ≤ÔºåËæÖÂä©ÂåªÁîüËøõË°åËØäÊñ≠ÂíåÊ≤ªÁñóÊñπÊ°àÂà∂ÂÆö„ÄÇËØ•Ê®°ÂûãÁöÑÈ´òÊïàÊÄßÂíåÈ≤ÅÊ£íÊÄß‰ΩøÂÖ∂Êõ¥Êòì‰∫éÈÉ®ÁΩ≤Âà∞ÂÆûÈôÖ‰∏¥Â∫äÁéØÂ¢É‰∏≠ÔºåÊúâÊúõÊèêÈ´òËØäÊñ≠ÊïàÁéáÂíåÂáÜÁ°ÆÊÄßÔºåÂπ∂‰∏∫ÊÇ£ËÄÖÊèê‰æõÊõ¥‰∏™ÊÄßÂåñÁöÑÊ≤ªÁñóÊñπÊ°à„ÄÇÊú™Êù•ÔºåËØ•ÊñπÊ≥ïÂèØ‰ª•Êâ©Â±ïÂà∞ÂÖ∂‰ªñÂô®ÂÆòÊàñÁñæÁóÖÁöÑÂàÜÂâ≤‰ªªÂä°‰∏≠„ÄÇ

## üìÑ ÊëòË¶ÅÔºàÂéüÊñáÔºâ

> Accurate brain tumor segmentation is significant for clinical diagnosis and treatment but remains challenging due to tumor heterogeneity. Mamba-based State Space Models have demonstrated promising performance. However, despite their computational efficiency over other neural architectures, they incur considerable overhead for this task due to their sequential feature computation across multiple spatial axes. Moreover, their robustness across diverse BraTS data partitions remains largely unexplored, leaving a critical gap in reliable evaluation. To address this, we first propose a dual-resolution bi-directional Mamba (DRBD-Mamba), an efficient 3D segmentation model that captures multi-scale long-range dependencies with minimal computational overhead. We leverage a space-filling curve to preserve spatial locality during 3D-to-1D feature mapping, thereby reducing reliance on computationally expensive multi-axial feature scans. To enrich feature representation, we propose a gated fusion module that adaptively integrates forward and reverse contexts, along with a quantization block that improves robustness. We further propose five systematic folds on BraTS2023 for rigorous evaluation of segmentation techniques under diverse conditions and present analysis of common failure scenarios. On the 20% test set used by recent methods, our model achieves Dice improvements of 0.10% for whole tumor, 1.75% for tumor core, and 0.93% for enhancing tumor. Evaluations on the proposed systematic folds demonstrate that our model maintains competitive whole tumor accuracy while achieving clear average Dice gains of 1.16% for tumor core and 1.68% for enhancing tumor over existing state-of-the-art. Furthermore, our model achieves a 15x efficiency improvement while maintaining high segmentation accuracy, highlighting its robustness and computational advantage over existing methods.

